Suppr超能文献

¹⁸F-FDG PET/CT在细针穿刺活检结果不确定的甲状腺结节手术选择中的应用:一项系统评价和荟萃分析

Performance of F-FDG PET/CT in Selecting Thyroid Nodules with Indeterminate Fine-Needle Aspiration Cytology for Surgery. A Systematic Review and a Meta-Analysis.

作者信息

Castellana Marco, Trimboli Pierpaolo, Piccardo Arnoldo, Giovanella Luca, Treglia Giorgio

机构信息

Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Emergency and Organ Transplantation, University of Bari Aldo Moro, IT-70124 Bari, Italy.

Clinic for Nuclear Medicine and Competence Center for Thyroid Diseases, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, CH-6500 Bellinzona, Switzerland.

出版信息

J Clin Med. 2019 Aug 28;8(9):1333. doi: 10.3390/jcm8091333.

Abstract

Thyroid nodules with indeterminate fine-needle aspiration cytology (FNA) represent a major challenge in clinical practice. We conducted a systematic review and meta-analysis evaluating the ability of hybrid imaging using fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (F-FDG PET/CT) to appropriately select these nodules for surgery. PubMed, CENTRAL, Scopus, and Web of Science were searched until July 2019. Original articles reporting data on the performance of F-FDG PET/CT in thyroid nodules with indeterminate FNA were included. Summary operating points including 95% confidence interval values (95% CI) were estimated using a random-effects model. Out of 786 retrieved papers, eight studies evaluating 104 malignant and 327 benign thyroid nodules were included. The pooled positive and negative likelihood ratios (LR+ and LR-) and diagnostic odds ratio (DOR) of F-FDG PET/CT were 1.7 (95% CI: 1.4-2.0), 0.4 (95% CI: 0.2-0.7), and 3.5 (95% CI: 1.7-7.1), respectively. No heterogeneity was found for LR+ and DOR. In patients with thyroid nodules with indeterminate FNA, F-FDG PET/CT has a moderate ability to correctly discriminate malignant from benign lesions and could represent a reliable option to reduce unnecessary diagnostic surgeries. However, further studies using standardized criteria for interpretation are needed to confirm the reproducibility of these findings.

摘要

细针穿刺细胞学检查(FNA)结果不确定的甲状腺结节是临床实践中的一项重大挑战。我们进行了一项系统评价和荟萃分析,评估使用氟-18-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(F-FDG PET/CT)的混合成像技术对这些结节进行手术选择的能力。检索了PubMed、CENTRAL、Scopus和Web of Science数据库,截至2019年7月。纳入了报告F-FDG PET/CT在FNA结果不确定的甲状腺结节中表现数据的原始文章。使用随机效应模型估计包括95%置信区间值(95%CI)在内的汇总操作点。在检索到的786篇论文中,纳入了8项评估104个恶性和327个良性甲状腺结节的研究。F-FDG PET/CT的汇总阳性和阴性似然比(LR+和LR-)以及诊断比值比(DOR)分别为1.7(95%CI:1.4-2.0)、0.4(95%CI:0.2-0.7)和3.5(95%CI:1.7-7.1)。LR+和DOR未发现异质性。在FNA结果不确定的甲状腺结节患者中,F-FDG PET/CT有中等能力正确区分恶性和良性病变,并且可能是减少不必要诊断性手术的可靠选择。然而,需要进一步使用标准化解释标准的研究来证实这些结果的可重复性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/194d/6780221/a63f4ee77ef3/jcm-08-01333-g001.jpg

相似文献

2
[F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.
Eur J Nucl Med Mol Imaging. 2022 May;49(6):1970-1984. doi: 10.1007/s00259-021-05627-2. Epub 2022 Jan 4.
4
Performance of Five Ultrasound Risk Stratification Systems in Selecting Thyroid Nodules for FNA.
J Clin Endocrinol Metab. 2020 May 1;105(5). doi: 10.1210/clinem/dgz170.
5
Quantitative classification and radiomics of [F]FDG-PET/CT in indeterminate thyroid nodules.
Eur J Nucl Med Mol Imaging. 2022 Jun;49(7):2174-2188. doi: 10.1007/s00259-022-05712-0. Epub 2022 Feb 9.
7
The dilemma of F-FDG PET/CT thyroid incidentaloma: what we should expect from FNA. A systematic review and meta-analysis.
Endocrine. 2021 Sep;73(3):540-549. doi: 10.1007/s12020-021-02683-4. Epub 2021 Mar 24.

引用本文的文献

2
3
Further explanations about the role of thyroid scintigraphy in the era of TIRADS.
Endocrine. 2024 Oct;86(1):124-126. doi: 10.1007/s12020-024-03912-2. Epub 2024 Jun 20.
4
Reappraising the role of thyroid scintigraphy in the era of TIRADS: A clinically-oriented viewpoint.
Endocrine. 2024 Sep;85(3):1035-1040. doi: 10.1007/s12020-024-03825-0. Epub 2024 Apr 16.
5
Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review.
Endocrine. 2024 Aug;85(2):473-492. doi: 10.1007/s12020-024-03737-z. Epub 2024 Feb 28.
6
Integrated Diagnostics of Thyroid Nodules.
Cancers (Basel). 2024 Jan 11;16(2):311. doi: 10.3390/cancers16020311.
7
Improving the TIR3B oncological stratification: try to bridge the gap through a comprehensive presurgical algorithm.
J Endocrinol Invest. 2024 Mar;47(3):633-643. doi: 10.1007/s40618-023-02182-5. Epub 2023 Sep 22.
8
Thyroid Nodules: Emerging Trends in Detection and Visualization based on Citespace.
Endocr Metab Immune Disord Drug Targets. 2024;24(1):130-141. doi: 10.2174/1871530323666230822143549.
9
Triple Assessment in Diagnosis of Thyroid Nodules and Its Comparison With Histopathology.
Cureus. 2023 Mar 11;15(3):e36021. doi: 10.7759/cureus.36021. eCollection 2023 Mar.

本文引用的文献

1
Radioisotope imaging for discriminating benign from malignant cytologically indeterminate thyroid nodules.
Gland Surg. 2019 Aug;8(Suppl 2):S118-S125. doi: 10.21037/gs.2019.03.06.
2
PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art.
Rev Endocr Metab Disord. 2019 Mar;20(1):47-64. doi: 10.1007/s11154-019-09491-2.
4
PET/CT and prediction of thyroid cancer in patients with follicular neoplasm or atypia.
Eur Arch Otorhinolaryngol. 2018 Aug;275(8):2109-2117. doi: 10.1007/s00405-018-5030-4. Epub 2018 Jun 16.
7
The 2017 Bethesda System for Reporting Thyroid Cytopathology.
Thyroid. 2017 Nov;27(11):1341-1346. doi: 10.1089/thy.2017.0500.
8
Role of positron emission tomography in thyroid and neuroendocrine tumors.
Minerva Endocrinol. 2018 Sep;43(3):341-355. doi: 10.23736/S0391-1977.17.02742-0. Epub 2017 Sep 25.
10
A prospective cohort study to assess the role of FDG-PET in differentiating benign and malignant follicular neoplasms.
Ann Med Surg (Lond). 2016 Oct 31;12:27-31. doi: 10.1016/j.amsu.2016.10.008. eCollection 2016 Dec.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验